Reuters logo
BRIEF-Mayne Pharma adds two products to its Australian portfolio
September 15, 2017 / 1:06 AM / 2 months ago

BRIEF-Mayne Pharma adds two products to its Australian portfolio

Sept 15 (Reuters) - Mayne Pharma Group Ltd

* Mayne Pharma adds two products to its Australian portfolio

* Mayne Pharma received TGA approval for Monurol (fosfomycin trometamol) (3g) granules and launched Urorec (silodosin) (8mg) capsules in Australia Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below